The dataset shows filings rising to 23 families in 2019, the highest point across the 2017-2026 window, before falling sharply to a single family by the 2022 midpoint. This pattern typically means the core formulation claim space — the basic photocurable and functional resin compositions usable in vat photopolymerization — was substantially staked out during the initial filing wave. Later applicants either consolidate around existing positions with narrower continuation filings or shift effort toward adjacent chemistries outside this search scope, such as ceramic-yielding preceramic polymers. The apparent 2025-2026 flatness should also be read with caution given the roughly 18-month gap between filing and publication.

Influence in this dataset is best read through citation counts rather than raw filing volume, and the two most-cited records both concern foaming radiation-curable resin for additive manufacturing, cited 21 and 18 times respectively. A separate, closely related record on stereolithography with micron-scale property control and one on resin formulation more generally also rank among the top five most-cited filings. These citation leaders function as reference points that later formulation claims are commonly measured against during examination, which makes them a sensible starting point for any competitive review.

The clearest gaps sit outside the two dominant subclasses, B33Y and B29C, which together cover the vast majority of the 81 tracked families. Condensation polymer chemistry (C08G), vinyl and addition polymer chemistry (C08F), and photolithography-adjacent formulation work (G03F) each appear in only a minority of records. Implant-specific resin applications under A61F are the smallest category tracked, at six records, suggesting biocompatible or medical-grade formulation claims remain comparatively open relative to general industrial resin chemistry.

Independently, almost entirely. Only two co-assignee pairs appear across the full 81-family dataset, and each is capped at four shared filings — one pairing involves a university-affiliated intellectual-property entity and a specialty polymer manufacturer, the other pairs two device manufacturers. This is a strong signal that most innovation in this niche is happening inside single organisations rather than through joint ventures or formal research consortia, which matters for anyone mapping potential licensing or acquisition targets.

Filed by UT-Battelle in January 2026, this application addresses control of crosslinking in hybrid preceramic polymers during vat photopolymerization, specifically targeting how crosslinking chemistry affects ceramic yield when volatile elements are involved. Its own abstract frames the crosslinking-to-yield relationship as still open for systematic investigation, which means the claims are likely to be relatively narrow and process-specific rather than blocking broad formulation approaches. Companies working on general photocurable resins are unlikely to be directly blocked by it, but anyone pursuing polymer-derived ceramic yield control via vat photopolymerization should review its specific claim language closely.